See more : Barton Gold Holdings Limited (BGD.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Telescope Innovations Corp. (TELIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Telescope Innovations Corp., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- AirTrip Corp. (EOVBF) Income Statement Analysis – Financial Results
- Amilot Capital Inc. (FMXVF) Income Statement Analysis – Financial Results
- SWOJAS ENERGY FOODS LTD. (SWOEF.BO) Income Statement Analysis – Financial Results
- SpotLite360 IOT Solutions, Inc. (LITE.CN) Income Statement Analysis – Financial Results
- Margaret Lake Diamonds Inc. (DIA.V) Income Statement Analysis – Financial Results
Telescope Innovations Corp. (TELIF)
About Telescope Innovations Corp.
Telescope Innovations Corp., a chemical technology company, engages in developing synthetic processes to access pharmaceuticals for the treatment of mental health. The company is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 2.82M | 595.40K | 0.00 | 0.00 |
| Cost of Revenue | 3.50K | 930.15K | 15.65K | 0.00 |
| Gross Profit | 2.82M | -334.75K | -15.65K | 0.00 |
| Gross Profit Ratio | 99.88% | -56.22% | 0.00% | 0.00% |
| Research & Development | 0.00 | 59.56K | 129.83K | 221.25K |
| General & Administrative | 2.25M | 5.60M | 3.72M | 140.06K |
| Selling & Marketing | 82.85K | 13.32K | 4.90K | 20.16K |
| SG&A | 2.33M | 5.62M | 3.72M | 31.73K |
| Other Expenses | 0.00 | -930.15K | -15.65K | 0.00 |
| Operating Expenses | 3.54M | 6.35M | 4.02M | 252.98K |
| Cost & Expenses | 3.55M | 6.35M | 4.02M | 252.98K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 2.44K |
| Depreciation & Amortization | 303.60K | 276.34K | 236.56K | 206.30K |
| EBITDA | -421.78K | -5.49M | -4.02M | -252.98K |
| EBITDA Ratio | -14.94% | -922.15% | 0.00% | 0.00% |
| Operating Income | -725.38K | -5.77M | -4.02M | -252.98K |
| Operating Income Ratio | -25.69% | -968.56% | 0.00% | 0.00% |
| Total Other Income/Expenses | 3.64K | 9.87K | -1.71K | 2.00 |
| Income Before Tax | -718.09K | -5.75M | -4.03M | -252.98K |
| Income Before Tax Ratio | -25.43% | -965.24% | 0.00% | 0.00% |
| Income Tax Expense | -3.64K | -9.87K | -885.06K | -233.52K |
| Net Income | -718.09K | -5.75M | -4.03M | -252.98K |
| Net Income Ratio | -25.43% | -965.24% | 0.00% | 0.00% |
| EPS | -0.01 | -0.12 | -0.08 | -0.01 |
| EPS Diluted | -0.01 | -0.12 | -0.08 | -0.01 |
| Weighted Avg Shares Out | 52.72M | 48.42M | 47.79M | 47.79M |
| Weighted Avg Shares Out (Dil) | 52.72M | 48.42M | 47.79M | 47.79M |
Telescope Innovations Is Granted a Canadian Patent on Chemical Synthesis Route
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been granted a Canadian...
Telescope Innovations Receives Accelerator Funding to Develop Carbon-Negative Production of Battery Materials
Vancouver, British Columbia--(Newsfile Corp. - July 11, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been awarded $292,333 through...
Source: https://incomestatements.info
Category: Stock Reports